The identified upregulation of Lrrk2 expression, a member of the leucine-rich repeat kinase family and mutations that have been associated with Parkinson’s disease, may be relevant in the context of previously described enhancement of dopaminergic neurotransmission in the TAAR5-KO mouse striatum. The gene discussed is LRRK2; the disease is Parkinson disease.